Cargando…

Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement

In August 2020, pharmacists were authorized to prescribe contraceptives in Minnesota outside of a collaborative practice agreement. To practice under this new authorization, pharmacists must complete formal contraceptive prescribing training and follow guidelines which include restrictions on patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Facciolo, Federico, Farley, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119991/
https://www.ncbi.nlm.nih.gov/pubmed/35601594
http://dx.doi.org/10.24926/iip.v12i3.3923
_version_ 1784710806579970048
author Facciolo, Federico
Farley, Joel
author_facet Facciolo, Federico
Farley, Joel
author_sort Facciolo, Federico
collection PubMed
description In August 2020, pharmacists were authorized to prescribe contraceptives in Minnesota outside of a collaborative practice agreement. To practice under this new authorization, pharmacists must complete formal contraceptive prescribing training and follow guidelines which include restrictions on patient’s age and appropriate screening and assessment requirements. Allowing pharmacists to prescribe contraceptives has the potential to extend contraceptive access, decrease overall health care costs, and improve outcomes. However, barriers to the expansion of contraceptive prescribing by pharmacists may prevent widespread adoption of this practice in Minnesota. A key concern among pharmacists is a lack of reimbursement for providing this service. Other states adopting contraceptive prescribing by pharmacists which have not paid for this service have reported limited implementation and discontinuation of this service. To improve contraceptive access to Minnesotans, policymakers should consider expanding provider status to pharmacists and providing reimbursement to pharmacists for contraceptive services.
format Online
Article
Text
id pubmed-9119991
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher University of Minnesota Libraries Publishing
record_format MEDLINE/PubMed
spelling pubmed-91199912022-05-20 Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement Facciolo, Federico Farley, Joel Innov Pharm Commentary In August 2020, pharmacists were authorized to prescribe contraceptives in Minnesota outside of a collaborative practice agreement. To practice under this new authorization, pharmacists must complete formal contraceptive prescribing training and follow guidelines which include restrictions on patient’s age and appropriate screening and assessment requirements. Allowing pharmacists to prescribe contraceptives has the potential to extend contraceptive access, decrease overall health care costs, and improve outcomes. However, barriers to the expansion of contraceptive prescribing by pharmacists may prevent widespread adoption of this practice in Minnesota. A key concern among pharmacists is a lack of reimbursement for providing this service. Other states adopting contraceptive prescribing by pharmacists which have not paid for this service have reported limited implementation and discontinuation of this service. To improve contraceptive access to Minnesotans, policymakers should consider expanding provider status to pharmacists and providing reimbursement to pharmacists for contraceptive services. University of Minnesota Libraries Publishing 2021-06-10 /pmc/articles/PMC9119991/ /pubmed/35601594 http://dx.doi.org/10.24926/iip.v12i3.3923 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Facciolo, Federico
Farley, Joel
Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement
title Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement
title_full Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement
title_fullStr Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement
title_full_unstemmed Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement
title_short Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement
title_sort minnesota policy on pharmacist-prescribed contraceptives: benefits, limitations, and opportunities for improvement
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119991/
https://www.ncbi.nlm.nih.gov/pubmed/35601594
http://dx.doi.org/10.24926/iip.v12i3.3923
work_keys_str_mv AT facciolofederico minnesotapolicyonpharmacistprescribedcontraceptivesbenefitslimitationsandopportunitiesforimprovement
AT farleyjoel minnesotapolicyonpharmacistprescribedcontraceptivesbenefitslimitationsandopportunitiesforimprovement